Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
47
Number of overlapping holdings
36.4%
% of BMED's 147 holdings also in XBI
36.2%
% of XBI's 131 holdings also in BMED
Overlap by Weight
Sector Drift (BMED minus XBI)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in BMED |
Weight in XBI |
Overlap | |
---|---|---|---|---|
ALNYLAM PHARMACEUTICALS INC | 1.6% | 1.1% | 1.1% | |
SAREPTA THERAPEUTICS INC | 1.4% | 1.1% | 1.1% | |
BIOMARIN PHARMACEUTICAL INC | 1.8% | 1.1% | 1.1% | |
NEUROCRINE BIOSCIENCES INC | 1.3% | 1.1% | 1.1% | |
BLUEPRINT MEDICINES CORP. | 1.5% | 1.1% | 1.1% |
Position Highlights (Non-Overlapping Exposures)
BMED Overweight Relative to XBI
BOSTON SCIENTIFIC CORP | 3.5% | |
AMERISOURCEBERGEN CORP | 3.1% | |
INTUITIVE SURGICAL INC | 2.3% | |
COOPER COS INC/THE | 2.1% | |
NOVO NORDISK A/S-B | 2.1% | |
ALIGN TECHNOLOGY INC | 2.0% | |
WEST PHARMACEUTICAL SERVICES | 2.0% | |
ARGENX SE ADR | 1.8% | |
ELI LILLY & CO | 1.7% | |
QIAGEN NV | 1.6% |
BMED Underweight Relative to XBI
CRINETICS PHARMACEUTICALS INC | -1.2% | |
CYTOKINETICS INC | -1.2% | |
NATERA INC | -1.2% | |
KRYSTAL BIOTECH, INC. | -1.1% | |
ARCUTIS BIOTHERAPEUTICS INC | -1.1% | |
MODERNA, INC. | -1.1% | |
IMMUNOVANT INC | -1.1% | |
REGENERON PHARMACEUTICALS | -1.0% | |
VERICEL CORPORATION | -1.0% | |
AMICUS THERAPEUTICS INC | -1.0% |